ADB CAPITAL MANAGEMENT
ADB Capital Management focuses on helping individuals identify financial goals and manage resources. The firm also provides quality retirement plan solutions to help organizations retain employees and provide better retirement outcomes.
ADB CAPITAL MANAGEMENT
Industry:
Finance Financial Services Wealth Management
Address:
Eugene, Oregon, United States
Country:
United States
Website Url:
http://www.adbcap.com
Total Employee:
1+
Status:
Active
Contact:
+1 541 302 5814
Email Addresses:
[email protected]
Similar Organizations
Brol Capital Management
Brol Capital Management works to provide wealth management advice.
Fountainhead Capital Management, Llc
Fountainhead Capital Management offers a new approach to wealth management.
Insight Investment Counsel
Insight Investment Counsel is a full service, independent wealth management firm.
Norrep Capital Management
Norrep Capital Management provides Canadians with an independent choice for their investments.
Parks Wealth Management
Parks Wealth Management is an independent wealth management firm in Ridgewood, New Jersey.
Pazera Capital Management
Pazera Capital Management, Inc. is an independent wealth management firm located in Houston and Rockport, Texas.
Quadravest Capital Management
Quadravest Capital Management Inc. is an independent investment management firm.
Spectrum Wealth Management
Spectrum Wealth Management is an independent boutique wealth management firm.
Verde Capital Management
Verde Capital Management is a money management and wealth management firm.
Waterloo Capital
Waterloo Capital is an independent wealth management firm.
Windham Capital Management
Windham Capital Management is an independent asset management firm.
More informations about "ADB Capital Management"
Advanced Accelerator Applications - Crunchbase
Organization. Advanced Accelerator Applications . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AAA is an …See details»
Welcome to the PLUVICTO(TM) Resource HUB
Advanced Accelerator Applications Canada, Inc., a Novartis Company. 2810 Matheson Blvd. E., Suite 700 Mississauga, Ontario, L4W 4X7 Canada www.adacap.comSee details»
S. BUONO | CEO | Advanced Accelerator Applications …
Stefano Buono is an accomplished physicist and alumnus of The European Organization for Nuclear Research (CERN). For the past 15 years, Mr. Buono …See details»
Advanced Accelerator Applications Information - RocketReach
Adacap.com; novartis.com; 2 845271XXXX; 845729XXXX; Thierry Barsalou Deputy Head IT and Senior Global Head Service Delivery at Advanced Accelerator Applications Geneva, GE, CH …See details»
Novartis completes tender offer for Advanced Accelerator …
Basel, January 22, 2018 - Novartis AG (NYSE: NVS) today announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase all of the …See details»
Advanced Accelerator Applications — Wikipédia
Advanced Accelerator Applications (AAA) (NASDAQ: AAAP) est un groupe pharmaceutique spécialisé en médecine nucléaire moléculaire. L’activité du groupe est axée sur les 3 …See details»
Advanced Accelerator Applications - ZoomInfo
Jan 11, 2024 Advanced Accelerator Applications contact info: Phone number: +33 450993070 Website: www.adacap.com What does Advanced Accelerator Applications do? Founded in …See details»
Novartis announces the planned acquisition of Advanced …
Basel, October 30, 2017 - Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to …See details»
Cartography of the Geneva Health Hub - Health field concerned ...
Advanced Accelerator Applications is reimagining nuclear medicine and cancer care. Its mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and …See details»
Health Canada approves PLUVICTO™ as first targeted …
Sep 7, 2022 Health Canada approves PLUVICTO™ as first targeted radioligand therapy for progressive PSMA‑positive metastatic castration-resistant prostate cancer FrançaisSee details»
Radiopharmaceutical cancer treatment Lutathera® now available …
Oct 8, 2020 Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs; Lutathera directly targets tumours by binding to …See details»
Advanced Accelerator Applications SA (Advanced Accelerator …
了解Advanced Accelerator Applications SA (Advanced Accelerator Applications SA)公司的药物管线，治疗领域，技术平台，以及它的45项临床试验, 10篇新闻和8篇文献，疾病领域:肿瘤，神 …See details»
Advanced Accelerator Applications Receives Positive CHMP
Jun 6, 2019 Advanced Accelerator Applications Receives Positive CHMP Opinion for LysaKare ® for Reduction of Kidney Exposure to Radiation During Peptide Receptor Radionuclide …See details»
Advanced Accelerator Applications Announces Completion of
Jan 22, 2018 [email protected] Tel: + 1-212-235-2395. AAA Investor Relations Jordan Silverstein Head of Investor Relations [email protected]See details»
Working at Advanced Accelerator Applications - Glassdoor
**AAA is a Novartis company, which is a phenomenal organization to be a part of! **The Company's mission is to change patients' lives by developing and delivering radioligand …See details»
Advanced Accelerator Applications - PitchBook
Nov 16, 2015 Information on acquisition, funding, cap tables, investors, and executives for Advanced Accelerator Applications. Use the PitchBook Platform to explore the full profile.See details»
Advanced Accelerator Applications and Blue Earth Diagnostics
May 30, 2017 Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA), an international specialist in Molecular Nuclear Medicine, and Blue Earth Diagnostics Ltd., a molecular imaging …See details»
Tumeurs neuroendocrines gastro-entéro-pancréatiques : le …
Oct 2, 2017 Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA), entreprise internationale spécialisée en médecine nucléaire moléculaire (MNM), a annoncé aujourd'hui …See details»
Advanced Accelerator Applications Receives FDA Approval for
Basel, January 26, 2018 - Novartis AG (NYSE: NVS) today announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug …See details»
A Randomized clinical trial evaluating the impact on survival and ...
2 days ago The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol Off Publ Int …See details»